Header Logo

Connection

LEILA SAHNI to Humans

Back to Details
This is a "connection" page, showing publications LEILA SAHNI has written about Humans.
LEILA SAHNI
Connection Strength
0.536
Humans
  1. Maternal Vaccine Effectiveness Against Influenza-Associated Hospitalizations and Emergency Department Visits in Infants. JAMA Pediatr. 2024 02 01; 178(2):176-184.
    View in: PubMed
    Score: 0.023
  2. Factors Associated With COVID-19 Non-vaccination in Adolescents Hospitalized Without COVID-19. J Pediatric Infect Dis Soc. 2023 Feb 09; 12(1):29-35.
    View in: PubMed
    Score: 0.021
  3. Sustained Within-season Vaccine Effectiveness Against Influenza-associated Hospitalization in Children: Evidence From the New Vaccine Surveillance Network, 2015-2016 Through 2019-2020. Clin Infect Dis. 2023 02 08; 76(3):e1031-e1039.
    View in: PubMed
    Score: 0.021
  4. Comparison of Mid-Turbinate and Nasopharyngeal Specimens for Molecular Detection of SARS-CoV-2 Among Symptomatic Outpatients at a Pediatric Drive-Through Testing Site. J Pediatric Infect Dis Soc. 2021 Sep 23; 10(8):872-879.
    View in: PubMed
    Score: 0.020
  5. Arboviral Surveillance among Pediatric Patients with Acute Febrile Illness in Houston, Texas. Am J Trop Med Hyg. 2018 08; 99(2):413-416.
    View in: PubMed
    Score: 0.016
  6. Understanding the Financial Implications of Immunization Reminder/Recall in a Multipractice Pediatric Group. Acad Pediatr. 2017 04; 17(3):323-329.
    View in: PubMed
    Score: 0.013
  7. Variation in rotavirus vaccine coverage by provider location and subsequent disease burden. Pediatrics. 2015 Feb; 135(2):e432-9.
    View in: PubMed
    Score: 0.012
  8. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis. 2012 Oct; 206(8):1275-9.
    View in: PubMed
    Score: 0.010
  9. Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine. 2010 Aug 31; 28(38):6314-7.
    View in: PubMed
    Score: 0.009
  10. Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Clin Infect Dis. 2025 Oct 06; 81(3):623-633.
    View in: PubMed
    Score: 0.006
  11. Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Netw Open. 2025 Sep 02; 8(9):e2531499.
    View in: PubMed
    Score: 0.006
  12. Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 01; 156(3).
    View in: PubMed
    Score: 0.006
  13. Acute Gastroenteritis Among Household Contacts of Children with Severe Norovirus Gastroenteritis, United States, 2011-2016. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
    View in: PubMed
    Score: 0.006
  14. Adenovirus Species in U.S. Children With Acute Respiratory Illness, 2016-2019. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
    View in: PubMed
    Score: 0.006
  15. Prevalence of human adenovirus in children with acute gastroenteritis in the New Vaccine Surveillance Network (NVSN) from 2016 to 2019. J Clin Virol. 2025 Aug; 179:105822.
    View in: PubMed
    Score: 0.006
  16. Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020. Influenza Other Respir Viruses. 2025 Jun; 19(6):e70124.
    View in: PubMed
    Score: 0.006
  17. Epidemiology and genotypic diversity of rhinovirus in school-age children with acute respiratory illnesses seeking medical care. J Clin Virol. 2025 Aug; 179:105806.
    View in: PubMed
    Score: 0.006
  18. Interim Evaluation of Respiratory Syncytial Virus Hospitalization Rates Among Infants and Young Children After Introduction of Respiratory Syncytial Virus Prevention Products - United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 May 08; 74(16):273-281.
    View in: PubMed
    Score: 0.006
  19. Enterovirus D68-Associated Respiratory Illness in Children. JAMA Netw Open. 2025 05 01; 8(5):e259131.
    View in: PubMed
    Score: 0.006
  20. The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in US Children. J Pediatric Infect Dis Soc. 2025 Apr 08; 14(4).
    View in: PubMed
    Score: 0.006
  21. Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 Feb 27; 74(6):83-90.
    View in: PubMed
    Score: 0.006
  22. Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024. JAMA Pediatr. 2025 Feb 01; 179(2):179-187.
    View in: PubMed
    Score: 0.006
  23. Pediatric Clinical Influenza Disease by Type and Subtype 2015-2020: A Multicenter, Prospective Study. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1).
    View in: PubMed
    Score: 0.006
  24. Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020. JAMA Netw Open. 2024 12 02; 7(12):e2452512.
    View in: PubMed
    Score: 0.006
  25. Embracing Professionalism to Cultivate Vaccine Positivity and Reduce Vaccine Hesitancy. Pediatr Ann. 2024 Dec; 53(12):e465-e472.
    View in: PubMed
    Score: 0.006
  26. Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024 Nov 14; 73(45):1022-1029.
    View in: PubMed
    Score: 0.006
  27. Evaluation of a Modified Vesikari Severity Score as a Research Tool for Assessing Pediatric Acute Gastroenteritis. J Pediatric Infect Dis Soc. 2024 Nov 04; 13(10):547-550.
    View in: PubMed
    Score: 0.006
  28. On-time childhood vaccination before and during the COVID-19 pandemic in seven communities: Findings from the New Vaccine Surveillance Network. Vaccine. 2024 12 02; 42(26):126455.
    View in: PubMed
    Score: 0.006
  29. Rotavirus Vaccine Effectiveness Against Severe Acute Gastroenteritis: 2009-2022. Pediatrics. 2024 Oct 01; 154(4).
    View in: PubMed
    Score: 0.006
  30. Prevalence of SARS-CoV-2 in Children Identified by Preprocedural Testing at 5 US Children's Hospital Systems. Pediatr Infect Dis J. 2025 Jan 01; 44(1):47-53.
    View in: PubMed
    Score: 0.006
  31. Timing of influenza vaccination during pregnancy. Am J Obstet Gynecol MFM. 2024 Aug; 6(8):101427.
    View in: PubMed
    Score: 0.006
  32. Respiratory Syncytial Virus-Associated Hospitalizations in Children <5 Years: 2016-2022. Pediatrics. 2024 Jul 01; 154(1).
    View in: PubMed
    Score: 0.006
  33. Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023. MMWR Morb Mortal Wkly Rep. 2024 Apr 18; 73(15):330-338.
    View in: PubMed
    Score: 0.006
  34. Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children. JAMA Netw Open. 2024 04 01; 7(4):e248255.
    View in: PubMed
    Score: 0.006
  35. Medical Costs of Respiratory Syncytial Virus-Associated Hospitalizations and Emergency Department Visits in Children Aged Younger Than 5?Years: Observational Findings from the New Vaccine Surveillance Network, 2016-2019. J Pediatr. 2024 Aug; 271:114045.
    View in: PubMed
    Score: 0.006
  36. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024. MMWR Morb Mortal Wkly Rep. 2024 Mar 07; 73(9):209-214.
    View in: PubMed
    Score: 0.006
  37. Respiratory Syncytial Virus-Associated Hospitalizations Among Children <5 Years Old: 2016 to 2020. Pediatrics. 2024 Mar 01; 153(3).
    View in: PubMed
    Score: 0.006
  38. Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024. MMWR Morb Mortal Wkly Rep. 2024 Feb 22; 73(7):149-151.
    View in: PubMed
    Score: 0.006
  39. Respiratory viral detection in the plasma and cerebrospinal fluid (CSF) of young febrile infants. Influenza Other Respir Viruses. 2024 02; 18(2):e13250.
    View in: PubMed
    Score: 0.006
  40. Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National Network. Pediatr Infect Dis J. 2024 Mar 01; 43(3):242-249.
    View in: PubMed
    Score: 0.006
  41. SARS-CoV-2 Epidemiology and COVID-19 mRNA Vaccine Effectiveness Among Infants and Children Aged 6 Months-4 Years - New Vaccine Surveillance Network, United States, July 2022-September 2023. MMWR Morb Mortal Wkly Rep. 2023 Dec 01; 72(48):1300-1306.
    View in: PubMed
    Score: 0.006
  42. Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023. MMWR Morb Mortal Wkly Rep. 2023 Sep 29; 72(39):1057-1064.
    View in: PubMed
    Score: 0.006
  43. Risk Factors for Multisystem Inflammatory Syndrome in Children: A Case-control Investigation. Pediatr Infect Dis J. 2023 06 01; 42(6):e190-e196.
    View in: PubMed
    Score: 0.005
  44. BNT162b2 mRNA Vaccination Against Coronavirus Disease 2019 is Associated With a Decreased Likelihood of Multisystem Inflammatory Syndrome in Children Aged 5-18 Years-United States, July 2021 - April 2022. Clin Infect Dis. 2023 02 08; 76(3):e90-e100.
    View in: PubMed
    Score: 0.005
  45. Circulation of Rhinoviruses and/or Enteroviruses in Pediatric Patients With Acute Respiratory Illness Before and During the COVID-19 Pandemic in the US. JAMA Netw Open. 2023 02 01; 6(2):e2254909.
    View in: PubMed
    Score: 0.005
  46. Clinical Presentation and Severity of Adenovirus Detection Alone vs Adenovirus Co-detection With Other Respiratory Viruses in US Children With Acute Respiratory Illness from 2016 to 2018. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):430-439.
    View in: PubMed
    Score: 0.005
  47. Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021. MMWR Morb Mortal Wkly Rep. 2022 Oct 07; 71(40):1253-1259.
    View in: PubMed
    Score: 0.005
  48. Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection. Pediatr Infect Dis J. 2022 11 01; 41(11):891-898.
    View in: PubMed
    Score: 0.005
  49. Comparative analysis of three multiplex platforms for the detection of respiratory viral pathogens. J Clin Virol. 2022 11; 156:105274.
    View in: PubMed
    Score: 0.005
  50. Vaccine Effectiveness Against Influenza Hospitalization and Emergency Department Visits in 2 A(H3N2) Dominant Influenza Seasons Among Children <18 Years Old-New Vaccine Surveillance Network 2016-2017 and 2017-2018. J Infect Dis. 2022 08 12; 226(1):91-96.
    View in: PubMed
    Score: 0.005
  51. Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants. N Engl J Med. 2022 07 14; 387(2):109-119.
    View in: PubMed
    Score: 0.005
  52. Understanding Variation in Rotavirus Vaccine Effectiveness Estimates in the United States: The Role of Rotavirus Activity and Diagnostic Misclassification. Epidemiology. 2022 09 01; 33(5):660-668.
    View in: PubMed
    Score: 0.005
  53. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. N Engl J Med. 2022 05 19; 386(20):1899-1909.
    View in: PubMed
    Score: 0.005
  54. Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19-Associated Hospitalization in Infants Aged <6 Months - 17 States, July 2021-January 2022. MMWR Morb Mortal Wkly Rep. 2022 Feb 18; 71(7):264-270.
    View in: PubMed
    Score: 0.005
  55. Clinical Influenza Testing Practices in Hospitalized Children at United States Medical Centers, 2015-2018. J Pediatric Infect Dis Soc. 2022 Jan 27; 11(1):5-8.
    View in: PubMed
    Score: 0.005
  56. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14; 71(2):52-58.
    View in: PubMed
    Score: 0.005
  57. Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. N Engl J Med. 2022 02 24; 386(8):713-723.
    View in: PubMed
    Score: 0.005
  58. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-November 2018-2020. MMWR Morb Mortal Wkly Rep. 2021 Nov 26; 70(47):1623-1628.
    View in: PubMed
    Score: 0.005
  59. Influenza clinical testing and oseltamivir treatment in hospitalized children with acute respiratory illness, 2015-2016. Influenza Other Respir Viruses. 2022 03; 16(2):289-297.
    View in: PubMed
    Score: 0.005
  60. Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 22; 70(42):1483-1488.
    View in: PubMed
    Score: 0.005
  61. Effect of Vaccination on Preventing Influenza-Associated Hospitalizations Among Children During a Severe Season Associated With B/Victoria Viruses, 2019-2020. Clin Infect Dis. 2021 08 16; 73(4):e947-e954.
    View in: PubMed
    Score: 0.005
  62. Understanding Vaccine Hesitancy Among Parents of Children With Autism Spectrum Disorder and Parents of Children With Non-Autism Developmental Delays. J Child Neurol. 2021 09; 36(10):911-918.
    View in: PubMed
    Score: 0.005
  63. Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study. Pediatrics. 2021 08; 148(2).
    View in: PubMed
    Score: 0.005
  64. Comparison of Parental Report of Influenza Vaccination to Documented Records in Children Hospitalized With Acute Respiratory Illness, 2015-2016. J Pediatric Infect Dis Soc. 2021 Apr 30; 10(4):389-397.
    View in: PubMed
    Score: 0.005
  65. Vaccine Effectiveness Against Influenza Hospitalization Among Children in the United States, 2015-2016. J Pediatric Infect Dis Soc. 2021 Mar 26; 10(2):75-82.
    View in: PubMed
    Score: 0.005
  66. Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):609-612.
    View in: PubMed
    Score: 0.005
  67. Vaccine Effectiveness Against Pediatric Influenza Hospitalizations and Emergency Visits. Pediatrics. 2020 11; 146(5).
    View in: PubMed
    Score: 0.005
  68. Beliefs about causes of autism and vaccine hesitancy among parents of children with autism spectrum disorder. Vaccine. 2020 09 11; 38(40):6327-6333.
    View in: PubMed
    Score: 0.005
  69. Respiratory Syncytial Virus-Associated Hospitalizations Among Young Children: 2015-2016. Pediatrics. 2020 07; 146(1).
    View in: PubMed
    Score: 0.004
  70. Evidence for Household Transmission of Rotavirus in the United States, 2011-2016. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):181-187.
    View in: PubMed
    Score: 0.004
  71. Evaluating Partial Series Childhood Vaccination Services in a Mobile Clinic Setting. Clin Pediatr (Phila). 2020 06; 59(7):706-715.
    View in: PubMed
    Score: 0.004
  72. Association of Rotavirus Vaccination With Inpatient and Emergency Department Visits Among Children Seeking Care for Acute Gastroenteritis, 2010-2016. JAMA Netw Open. 2019 09 04; 2(9):e1912242.
    View in: PubMed
    Score: 0.004
  73. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. MMWR Morb Mortal Wkly Rep. 2019 Mar 29; 68(12):277-280.
    View in: PubMed
    Score: 0.004
  74. Factors Associated With Rotavirus Vaccine Coverage. Pediatrics. 2019 02; 143(2).
    View in: PubMed
    Score: 0.004
  75. Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013. J Infect Dis. 2016 09 01; 214(5):732-8.
    View in: PubMed
    Score: 0.003
  76. Molecular characterization of the first G24P[14] rotavirus strain detected in humans. Infect Genet Evol. 2016 09; 43:338-42.
    View in: PubMed
    Score: 0.003
  77. Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset? Vaccine. 2016 Mar 08; 34(11):1335-42.
    View in: PubMed
    Score: 0.003
  78. Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States. JAMA Pediatr. 2015 Nov; 169(11):1040-5.
    View in: PubMed
    Score: 0.003
  79. G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States. Emerg Infect Dis. 2015 Nov; 21(11):2103-4.
    View in: PubMed
    Score: 0.003
  80. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clin Infect Dis. 2015 Dec 15; 61(12):1792-9.
    View in: PubMed
    Score: 0.003
  81. The Texas Children's Hospital immunization forecaster: conceptualization to implementation. Am J Public Health. 2014 Dec; 104(12):e65-71.
    View in: PubMed
    Score: 0.003
  82. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013 Jul; 57(1):13-20.
    View in: PubMed
    Score: 0.003
  83. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J. 2010 Dec; 29(12):1133-5.
    View in: PubMed
    Score: 0.002
  84. Immunization information system opt-in consent: at what cost? J Public Health Manag Pract. 2010 Sep-Oct; 16(5):E18-25.
    View in: PubMed
    Score: 0.002
  85. Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. Pediatr Infect Dis J. 2010 Sep; 29(9):836-9.
    View in: PubMed
    Score: 0.002
  86. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010 Feb; 125(2):e199-207.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.